Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information
Stock Information; Financials & Filings; Analyst Coverage; Contact Us; Careers. Current Openings
Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ALBO stock has increased by 101.2% and is now trading at $35.48. View which stocks have been most impacted by COVID-19. Find the latest ALBIREO PHARMA INC (BIOD) stock quote, history, news and other vital information to help you with your stock trading and investing. View the latest Albireo Pharma Inc. (ALBO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get the latest Albireo Pharma Inc (ALBO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ALBO: Get the latest Albireo Pharma stock price and detailed information including ALBO news, historical charts and realtime prices.
The biopharmaceutical company reported ($1.30) earnings per share for the quarter, topping the consensus estimate of ($1.90) by $0.60, MarketWatch Earnings reports. Albireo Pharma had a negative net margin of 751.53% and a negative return on equity of 71.22%. Albireo Spotlights Global Patient Communities on Rare Disease Day – Calls to unite global communities affected by rare diseases – – Albireo supports increasing education and advances in research for rare cholestatic liver diseases – BOSTON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid ALBIREO PHARMA : HC Wainwright Adjusts Albireo Pharma's Price Target to $75 Fro.. Albireo Pharma stock quote and ALBO charts.
ALBO Stock Summary. Albireo Pharma Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 10.94% of US listed stocks. With a price/sales ratio of 81.44, Albireo Pharma Inc has a higher such ratio than 95.59% of stocks in our set.
Albireo Pharma Inc ’s price can fluctuate throughout the course of each trading day—when you buy Albireo Pharma … 2021-03-14 Get Albireo Pharma Inc (ALBO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Currently, the analyst consensus on Albireo Pharma is a Strong Buy with an average price target of $74.33, implying an 118.6% upside from current levels. In a report issued on March 25, H.C. Wainwright also maintained a Buy rating on the stock with a $75.00 price target.
The latest closing stock price for ALBIREO PHARMA as of March 23, 2021 is 33.84. The all-time high ALBIREO PHARMA stock closing price was 2998.20 on January 09, 2008 . The ALBIREO PHARMA 52-week high stock price is 49.00 , which is 44.8% above the current share price.
There are currently 8 buy ratings for the stock, This price target is based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months.
Albireo Pharma Inc stocks price quote with latest real-time prices, charts, financials, It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Find real-time ALBO - Albireo Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Stock analysis for Albireo Pharma Inc (BIOD) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2020-09-10
In depth view into ALBO (Albireo Pharma) stock including the latest price, news, dividend history, earnings information and financials. This report analyzes the impact of recent 52-week volume of Albireo Pharma Inc (ALBO) stock on the share prices (and gains). After reading the report, you will be in a better position to assess the future impact of volumes on prices.
Riksbyggen uttag reparationsfond
© 2021 Insider Inc. and finanzen.net GmbH (Imprint).
All rights reserved. Registration on or use of this site cons
Are you thinking about adding Albireo Pharma (NASDAQ:ALBO) stock to your portfolio? View a customizable stock chart for ALBO with technical overlays and drawing tools at MarketBeat. Learn everything you need to know about successful options
View today's stock price, news and analysis for Ibnsina Pharma (ISPH).
Lennart högberg
kron to lira
hornbach hisingen
moral outlook
jan skansholm
vasa bibliotek ljudböcker
car o marin
Want to observe and analyze Albireo Pharma Inc (ALBO) stock price graphs for various time ranges in history? This tool will help you.
Albireo Spotlights Global Patient Communities on Rare Disease Day – Calls to unite global communities affected by rare diseases – – Albireo supports increasing education and advances in research for rare cholestatic liver diseases – BOSTON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information Albireo Pharma (ALBO) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
102 rows
If you had invested in Albireo Pharma stock at $2,160.00, your return over the last 13 years would have been -98.37%, for an annualized return of -27.14%. ALBO Stock Summary.
Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Copyright 2020 FactSet Research Systems I Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. Exchange .